Latest News

  • childhood apraxia of speech trial (1)

    Childhood Apraxia of Speech Trial

    We are trialling a new treatment for children with childhood apraxia of speech (CAS). This treatment is the drug methylphenidate (MPH), commonly known as Ritalin. We want to find out whether MPH can help improve the speech and language symptoms of CAS in children aged 6-12 years.
    Hear Ms Lorraine O'Donnell, Registered Nurse and Coordinator of this trial, explain our study in this informative reel.

    Read More

  • Miya Square Copy Jpg

    Dr Miya St John awarded a Harold Mitchell Foundation Travelling Fellowship

    Dr Miya St John was awarded a Harold Mitchell Foundation Travelling Fellowship for her contribution to speech research.

    The funding enables showcasing her research internationally & strengthen global collaborations.

    Miya will use these funds to present at the International Koolen-de Vries Summit next July and learn a long-established therapy for Childhood Apraxia of Speech with our American colleagues.

    Read More

  • File SPA

    Celebrating Speech Pathology Week - Communicate Your Way

    We’re proud to have supported over 250 families, helping them find their unique voices and communicate in their own way. This week, we’re sharing exciting content on our Instagram and Facebook pages. Follow along so you don’t miss out!

    #SpeechPathologyWeek #CommunicateYourWay #SpeechPathology

    Read More

  • UCL GOS ICH

    Centre of Research Excellence (CRE) Symposium 7 June 2024

    The Centre of Research Excellence - Translational Centre for Speech Disorders is delighted to co-host their Symposium ‘What’s new since FOXP2: new developments in speech and language neurobiology' together with University College London (UCL) Great Ormond Street Institute of Child Health.

    Read More

  • PhD opportunity short pic

    Interested in studying a PhD examining speech and language phenotypes of Ataxia Telangiectasia (A-T) in children?

    We currently have an exciting PhD opportunity to examine Speech and Language phenotypes at the Ataxia Telangiectasia (A-T) clinic at the Queensland Children’s Hospital which is led by Prof. David Coman.

    For more information, please click here.

    Read More

  • Gene linked to persistent stuttering into adulthood uncovered

    Gene linked to persistent stuttering into adulthood uncovered

    A new study led by University of Melbourne researchers has discovered a link between a new gene pathway and structural brain anomalies in some people who stutter into adulthood, opening up promising research avenues to enhance the understanding of persistent developmental stuttering.

    Read More

  • PhD Opportunity Angelman Syndrome

    Interested in studying a PhD on speech and language function in Angelman Syndrome?

    We currently have a PhD opportunity to study speech and language function in Angelman Syndrome. For more information, please click here.

    Read More

  • Speechdisorders Logomark Primary Fullcolour

    Symposium - Child speech disorders: translating cutting-edge science into clinical practice

    The Centre of Research Excellence - Translational Centre for Speech Disorders is delighted to host their first Symposium on Monday 9 October 2023.

    Read More

  • Angela Morgan speaking pict

    New funding awarded for Centre of Research Excellence – Translational Centre for Speech Disorders

    The Speech and Language Team recently launched a Translational Centre for Speech Disorders following NHMRC Centre of Research Excellence funding awarded for a 5-year period. National and international experts will collaborate to study the neurobiology of speech disorders to better understand the cause of speech disorders such as apraxia of speech. Findings from this research will help transform diagnosis and prognosis and enable precision therapies to improve long term outcomes for children with speech disorders.

    For information on Prof Angela Morgan’s insights about this Translational Centre for Speech Disorders, please click here.

    Read More

  • PhD opportunity Emma Baker 2022

    Interested in studying a PhD on the neuropsychological profile of children with childhood apraxia of speech?

    We currently have a PhD opportunity. Applications close December 11th 2022. For more information, please click here or email emma.baker@mcri.edu.au.

    Read More

  • Neurology Picture

    New genes linked to childhood apraxia of speech

    Just published! We have recently published a number of genes newly associated with childhood apraxia of speech/severe speech disorder. These findings further our understanding of the heterogeneity of genetic contributions to the condition. For more information about the publication, please click here.

    Read More

  • Josh Earl

    MCRI and Josh Earl

    We have been fortunate enough to welcome a collaboration with the Melbourne based comedian Josh Earl. Josh is well known for his work in stand up, radio and television. He openly talks about his speech difficulties as a child in his stand-up routine. Josh will be working with our team to advocate for individuals with speech disorder. To learn more about Josh and his collaboration with MCRI, please click here. To learn more about Josh, please visit www.joshearl.com.au.

    Read More

  • Stuttering Picture

    Genetics of Stuttering Launch

    Recruitment for the Genetics of Stuttering study is well underway. Thank you to the 800+ individuals who have already participated! This has been a fantastic response, and participants have been true partners in helping us further refine our survey.

    Read More

  • Istock 000040965646 Large

    We are still recruiting!

    We are currently still recruiting for the Genetics of Speech and Genetics of Stuttering studies. If you are interested, or know someone that may be interested please do not hesitate to contact us at (03) 9936 6334 or geneticsofstuttering@mcri.edu.au

    Read More

Proudly in partnership with